









市場
/
株式
/
nasdaq-gild
/

Gilead Sciences Inc

GILD

124.700USD

-0.970-0.77%

終値 12/26, 16:00（ET）15分遅れの株価

154.88B時価総額

19.15直近12ヶ月PER



Gilead Sciences Inc

124.700

-0.970-0.77%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Gilead Sciences Inc 企業名

Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. It also develops the HB-400 program and the HB-500 program. It develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. It operates in more than 35 countries worldwide.

Gilead Sciences Incの企業情報



企業コードGILD

会社名Gilead Sciences Inc

上場日Jan 22, 1992

最高経営責任者「CEO」O'Day (Daniel P)

従業員数17600

証券種類Ordinary Share

決算期末Jan 22

本社所在地333 Lakeside Dr

都市FOSTER CITY

証券取引所NASDAQ OMX - NASDAQ BASIC

国United States of America

郵便番号94404-1147

電話番号16505743000

ウェブサイトhttps://www.gilead.com/

企業コードGILD

上場日Jan 22, 1992

最高経営責任者「CEO」O'Day (Daniel P)

Gilead Sciences Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Johanna Mercier

Chief Commercial Officer

79.97K

-3.62%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

26.06K

+6.18%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

11.75K

+14.82%

Ms. Kelly A. Kramer

Independent Director

1.34K

Ms. Erin Burkhart

Senior Vice President, Principal Accounting Officer, Controller

Dr. Dietmar P. Berger, M.D., Ph.D.

Chief Medical Officer

Mr. Andrew D. (Andy) Dickinson

Chief Financial Officer

Mr. Harish Manwani

Independent Director

Dr. Ted W. Love, M.D.

Independent Director

Mr. Javier J. Rodriguez

Independent Director

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Johanna Mercier

Chief Commercial Officer

79.97K

-3.62%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

26.06K

+6.18%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

11.75K

+14.82%

Ms. Kelly A. Kramer

Independent Director

1.34K

Ms. Erin Burkhart

Senior Vice President, Principal Accounting Officer, Controller

Dr. Dietmar P. Berger, M.D., Ph.D.

Chief Medical Officer

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

事業別USD

会社名

収益

比率

Biktarvy

3.53B

49.84%

Descovy

653.00M

9.22%

Yescarta

393.00M

5.55%

Genvoya

378.00M

5.34%

Trodelvy

364.00M

5.14%

他の

1.76B

24.91%

地域別USD

会社名

収益

比率

United States

5.00B

70.59%

Europe

1.17B

16.51%

Other Locations

792.00M

11.18%

事業別

地域別

事業別USD

会社名

収益

比率

Biktarvy

3.53B

49.84%

Descovy

653.00M

9.22%

Yescarta

393.00M

5.55%

Genvoya

378.00M

5.34%

Trodelvy

364.00M

5.14%

他の

1.76B

24.91%

株主

更新時刻: Sun, Nov 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

9.54%

BlackRock Institutional Trust Company, N.A.

5.86%

State Street Investment Management (US)

4.76%

Fidelity Management & Research Company LLC

4.34%

Capital World Investors

3.64%

他の

71.86%

株主統計

比率

The Vanguard Group, Inc.

9.54%

BlackRock Institutional Trust Company, N.A.

5.86%

State Street Investment Management (US)

4.76%

Fidelity Management & Research Company LLC

4.34%

Capital World Investors

3.64%

他の

71.86%

種類

株主統計

比率

Investment Advisor

54.42%

Investment Advisor/Hedge Fund

25.61%

Pension Fund

2.86%

Research Firm

2.81%

Hedge Fund

2.00%

Bank and Trust

1.90%

Sovereign Wealth Fund

1.73%

Insurance Company

0.15%

Venture Capital

0.10%

他の

8.41%

機関投資家保有株



更新時刻: Wed, Oct 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q3

3433

1.13B

91.16%

+23.58K

2025Q2

3388

1.12B

90.01%

-12.02M

2025Q1

3442

1.12B

90.14%

-10.49M

2024Q4

3313

1.12B

90.13%

+4.63M

2024Q3

3207

1.10B

88.48%

-11.56M

2024Q2

3188

1.10B

88.24%

-14.37M

2024Q1

3196

1.10B

88.13%

-22.04M

2023Q4

3252

1.11B

88.75%

-8.79M

2023Q3

3190

1.10B

88.14%

-23.58M

2023Q2

3196

1.10B

88.02%

-11.22M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

118.78M

9.57%

+1.87M

+1.60%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

70.80M

5.71%

+138.89K

+0.20%

Jun 30, 2025

State Street Investment Management (US)

59.19M

4.77%

-335.51K

-0.56%

Jun 30, 2025

Fidelity Management & Research Company LLC

53.76M

4.33%

+2.55M

+4.98%

Jun 30, 2025

Capital World Investors

46.30M

3.73%

-7.24M

-13.53%

Jun 30, 2025

Dodge & Cox

30.82M

2.48%

-1.88M

-5.74%

Jun 30, 2025

Capital Research Global Investors

31.10M

2.51%

-23.51M

-43.06%

Jun 30, 2025

Geode Capital Management, L.L.C.

29.21M

2.35%

+727.51K

+2.55%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

25.46M

2.05%

-89.95K

-0.35%

Aug 31, 2025

Wellington Management Company, LLP

37.53M

3.02%

+10.17M

+37.18%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 18.49B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Oct 30, 2025

GILD.NB Final Cash Dividend of gross USD 0.79 paid on Dec 30, 2025 going ex on Dec 15, 2025

Dec 15, 2025

Dec 30, 2025

Dec 15, 2025

Aug 07, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Sep 29, 2025 going ex on Sep 15, 2025

Sep 15, 2025

Sep 29, 2025

Sep 15, 2025

Apr 24, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Jun 27, 2025 going ex on Jun 13, 2025

Jun 13, 2025

Jun 27, 2025

Jun 13, 2025

Feb 11, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Mar 28, 2025 going ex on Mar 14, 2025

Mar 14, 2025

Mar 28, 2025

Mar 14, 2025

Nov 12, 2024

GILD.NB Final Cash Dividend of gross USD 0.77 paid on Dec 30, 2024 going ex on Dec 13, 2024

Dec 13, 2024

Dec 30, 2024

Dec 13, 2024

Aug 13, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Sep 27, 2024 going ex on Sep 13, 2024

Sep 13, 2024

Sep 27, 2024

Sep 13, 2024

Apr 26, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Jun 27, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jun 27, 2024

Jun 14, 2024

Feb 06, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Mar 28, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Mar 28, 2024

Mar 14, 2024

Nov 08, 2023

GILD.NB Final Cash Dividend of gross USD 0.75 paid on Dec 28, 2023 going ex on Dec 14, 2023

Dec 15, 2023

Dec 28, 2023

Dec 14, 2023

Aug 07, 2023

GILD.NB Interim Cash Dividend of gross USD 0.75 paid on Sep 28, 2023 going ex on Sep 14, 2023

Sep 15, 2023

Sep 28, 2023

Sep 14, 2023

詳細を見る

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

よくある質問

Gilead Sciences Incの上位5名の株主は誰ですか？



Gilead Sciences Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は118.78M株を保有しており、これは全体の9.57%に相当します。
BlackRock Institutional Trust Company, N.A.は70.80M株を保有しており、これは全体の5.71%に相当します。
State Street Investment Management (US)は59.19M株を保有しており、これは全体の4.77%に相当します。
Fidelity Management & Research Company LLCは53.76M株を保有しており、これは全体の4.33%に相当します。
Capital World Investorsは46.30M株を保有しており、これは全体の3.73%に相当します。